نتائج البحث - "Minal A. Barve"

1

دورية أكاديمية

P1108: EFFICACY OF PIRTOBRUTINIB, A HIGHLY SELECTIVE, NON-COVALENT (REVERSIBLE) BTK INHIBITOR IN RELAPSED/REFRACTORY WALDENSTRÖM MACROGLOBULINEMIA: RESULTS FROM THE PHASE 1/2 BRUIN STUDY

المصدر: HemaSphere, Vol 7, p e852670f (2023)

مصطلحات موضوعية: Diseases of the blood and blood-forming organs, RC633-647.5

وصف الملف: electronic resource

العلاقة: http://journals.lww.com/10.1097/01.HS9.0000971328.85267.0fTest; https://doaj.org/toc/2572-9241Test

الوصول الحر: https://doaj.org/article/a040220921ef4307b9e157dc91a3150bTest

View record in DOAJ

النص الكامل

2

دورية أكاديمية

Maximum Tolerated Dose and Anti-Tumor Activity of Intraperitoneal Cantrixil (TRX-E-002-1) in Patients with Persistent or Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer: Phase I Study Results

المؤلفون: Jermaine I. Coward, Minal A. Barve, Ganessan Kichenadasse, Kathleen N. Moore, Paul R. Harnett, Daniel Berg, James S. Garner, Don S. Dizon

المصدر: Cancers, Vol 13, Iss 13, p 3196 (2021)

مصطلحات موضوعية: ovarian cancer, platinum refractory, platinum resistant, intraperitoneal delivery, phase I, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

العلاقة: https://www.mdpi.com/2072-6694/13/13/3196Test; https://doaj.org/toc/2072-6694Test

الوصول الحر: https://doaj.org/article/940744a5dcaf4c8e801b3af526d9d726Test

View record in DOAJ

النص الكامل

3

Efficacy of Pirtobrutinib, a Highly Selective, Non-Covalent (Reversible) BTK Inhibitor in Relapsed / Refractory Waldenström Macroglobulinemia: Results from the Phase 1/2 BRUIN Study

المصدر: Blood. 140:557-560

مصطلحات موضوعية: Immunology, Cell Biology, Hematology, Biochemistry

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::e7b7b944cc4ca609ebe926d158de239aTest
https://doi.org/10.1182/blood-2022-159123Test

4

Safety and Tolerability of Pirtobrutinib Monotherapy in Patients with B-Cell Malignancies Who Were Previously Intolerant to a Covalent BTK Inhibitor: Results from the Phase 1/2 BRUIN Study

المصدر: Blood. 140:4127-4132

مصطلحات موضوعية: Immunology, Cell Biology, Hematology, Biochemistry

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::11ca7ccaa2fa19c892c00f18ad737622Test
https://doi.org/10.1182/blood-2022-159035Test

5

BETA PRIME: Phase I study of AdAPT-001 as monotherapy and combined with a checkpoint inhibitor in superficially accessible, treatment-refractory solid tumors

المؤلفون: Santosh Kesari, Alberto Bessudo, Brian R Gastman, Anthony P Conley, Victoria M Villaflor, Lisle M Nabell, DeLisa Madere, Emma Chacon, Christina Spencer, Li Li, Christopher Larson, Tony Reid, Scott Caroen, Bryan Oronsky, Meaghan Stirn, Jeannie Williams, Minal A Barve

المصدر: Future Oncology. 18:3245-3254

مصطلحات موضوعية: Oncolytic Virotherapy, Cancer Research, Clinical Trials, Phase I as Topic, Immunoglobulins, General Medicine, Mice, Oncology, Transforming Growth Factor beta, Cell Line, Tumor, Neoplasms, Animals, Cytokines, Humans, Immunotherapy, Receptors, Transforming Growth Factor beta

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::003bc519ae7f79ee18fae911d850ebfcTest
https://doi.org/10.2217/fon-2022-0481Test

6

First-in-Human Phase I/IB Dose-Finding Study of Adagrasib (MRTX849) in Patients With Advanced KRASG12C Solid Tumors (KRYSTAL-1)

المؤلفون: Sai-Hong Ignatius Ou, Pasi A. Jänne, Ticiana A. Leal, Igor I. Rybkin, Joshua K. Sabari, Minal A. Barve, Lyudmila Bazhenova, Melissa L. Johnson, Karen L. Velastegui, Cornelius Cilliers, James G. Christensen, Xiaohong Yan, Richard C. Chao, Kyriakos P. Papadopoulos

المصدر: Journal of Clinical Oncology. 40:2530-2538

مصطلحات موضوعية: Cancer Research, Oncology

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::f1fb4b19535ed09966713c2dfe149f4fTest
https://doi.org/10.1200/jco.21.02752Test

7

Abstract P2-13-45: Interim results of a phase 1 study of the novel immunotoxin MT-5111 in patients with HER2+tumors

المؤلفون: Brian A. Van Tine, Monica Mita, Minal A. Barve, Erika P. Hamilton, Andrew J. Brenner, Frances Valdes, Daniel Ahn, Joleen Hubbard, Jason Starr, Angela Georgy, Joshua Pelham, Banmeet S. Anand, Thomas Strack, Andrés Machado Sandri, Zev A. Wainberg

المصدر: Cancer Research. 82:P2-13

مصطلحات موضوعية: Cancer Research, Oncology

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::a9db99f3de1dd19cc31e0a6f2544d7b7Test
https://doi.org/10.1158/1538-7445.sabcs21-p2-13-45Test

8

Phase I Open-Label Study Evaluating the Safety, Pharmacokinetics, and Preliminary Efficacy of Dilpacimab in Patients with Advanced Solid Tumors

المؤلفون: Susan E. Morgan-Lappe, Zev A. Wainberg, Ramesh K. Ramanathan, Huibin Yue, Martha Elizabeth Blaney, Louie Naumovski, John H. Strickler, Lan Wang, John Nemunaitis, George W. Sledge, Erika Hamilton, Sreeneeranj Kasichayanula, Minal A. Barve, Michael S. Gordon, Monica Motwani

المصدر: Molecular cancer therapeutics, vol 20, iss 10

مصطلحات موضوعية: Vascular Endothelial Growth Factor A, Adult, Male, Cancer Research, medicine.medical_specialty, Maximum Tolerated Dose, Clinical Trials and Supportive Activities, Oncology and Carcinogenesis, Antineoplastic Agents, Gastroenterology, Antibodies, Prostate cancer, Rare Diseases, Pharmacokinetics, Clinical Research, Gastrointestinal perforation, Neoplasms, Internal medicine, Antibodies, Bispecific, medicine, Humans, Tissue Distribution, Oncology & Carcinogenesis, Adverse effect, Adaptor Proteins, Signal Transducing, Aged, Cancer, business.industry, Calcium-Binding Proteins, Signal Transducing, Adaptor Proteins, Evaluation of treatments and therapeutic interventions, Pharmacology and Pharmaceutical Sciences, Middle Aged, Prognosis, medicine.disease, Ovarian Cancer, Orphan Drug, Oncology, Tolerability, 6.1 Pharmaceuticals, Pharmacodynamics, Bispecific, Female, Patient Safety, Ovarian cancer, business, Progressive disease, Follow-Up Studies

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53aadea40691048a1e4ced92e1801356Test
https://doi.org/10.1158/1535-7163.mct-20-0985Test

9

KRYSTAL-1: Activity and safety of adagrasib (MRTX849) in patients with advanced solid tumors harboring a KRASG12C mutation

المؤلفون: Shubham Pant, Rona Yaeger, Alexander I. Spira, Meredith Pelster, Joshua K. Sabari, Navid Hafez, Minal A. Barve, Karen Velastegui, Xiaohong Yan, Hirak Der-Torossian, Tanios S. Bekaii-Saab

المصدر: Journal of Clinical Oncology. 41:425082-425082

مصطلحات موضوعية: Cancer Research, Oncology

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::8cb5982b3e2a4f1bb96840c19cac5944Test
https://doi.org/10.1200/jco.2023.41.36_suppl.425082Test

10

Effects of Rovalpituzumab Tesirine on Ventricular Repolarization in Patients With Small‐Cell Lung Cancer

المؤلفون: William Jeffery Edenfield, Daniel Da Costa, David Hoffman, Matthew P. Kosloski, Minal A. Barve, Scott A. Laurie, Alexander Starodub, Jonathan W. Goldman, Satwant Lally, Martina M. Koch, Afshin Dowlati, Antoinette J. Wozniak, Jyoti D. Patel, Grace K. Dy, Taofeek K. Owonikoko

المصدر: Clinical and Translational Science, Vol 14, Iss 2, Pp 664-670 (2021)
Clinical and Translational Science

مصطلحات موضوعية: Male, 030213 general clinical medicine, medicine.medical_specialty, Immunoconjugates, Lung Neoplasms, Antineoplastic Agents, Antibodies, Monoclonal, Humanized, 030226 pharmacology & pharmacy, QT interval, Article, General Biochemistry, Genetics and Molecular Biology, Electrocardiography, 03 medical and health sciences, QRS complex, 0302 clinical medicine, Heart Rate, Internal medicine, Heart rate, Humans, Medicine, General Pharmacology, Toxicology and Pharmaceutics, PR interval, Adverse effect, Aged, Aged, 80 and over, Proarrhythmia, Benzodiazepinones, business.industry, Research, General Neuroscience, lcsh:Public aspects of medicine, lcsh:RM1-950, Rovalpituzumab tesirine, lcsh:RA1-1270, Articles, General Medicine, Middle Aged, medicine.disease, Small Cell Lung Carcinoma, Cardiotoxicity, Confidence interval, Long QT Syndrome, lcsh:Therapeutics. Pharmacology, Cardiology, Female, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb4161d5156f1160f3f4b03e3fc16a32Test
https://doaj.org/article/accac0c4d8ab4b6a908935af63ca37f0Test

تنقيح النتائج